IRIS Institutional Research Information System - OPENBS Open Archive UniBS

URBINATI, Chiara Eva
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.428
EU - Europa 2.512
AS - Asia 1.773
SA - Sud America 194
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 7.936
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.391
PL - Polonia 1.141
SG - Singapore 658
CN - Cina 577
UA - Ucraina 371
HK - Hong Kong 301
DE - Germania 273
IT - Italia 187
BR - Brasile 180
FI - Finlandia 138
GB - Regno Unito 89
RU - Federazione Russa 84
IE - Irlanda 67
TR - Turchia 66
IN - India 53
VN - Vietnam 50
FR - Francia 48
CA - Canada 24
CZ - Repubblica Ceca 23
AT - Austria 20
SE - Svezia 19
ID - Indonesia 17
NL - Olanda 15
BD - Bangladesh 10
BE - Belgio 10
MA - Marocco 8
IL - Israele 7
ZA - Sudafrica 7
ES - Italia 6
EU - Europa 5
IR - Iran 5
AR - Argentina 4
EC - Ecuador 4
IQ - Iraq 4
JP - Giappone 4
MX - Messico 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
EE - Estonia 3
GR - Grecia 3
LT - Lituania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
LK - Sri Lanka 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PK - Pakistan 2
TN - Tunisia 2
UZ - Uzbekistan 2
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RE - Reunion 1
RS - Serbia 1
TT - Trinidad e Tobago 1
Totale 7.936
Salva come PNG Salva come JPEG
Città #
Warsaw 1.140
Woodbridge 415
Fairfield 382
Hong Kong 301
Jacksonville 275
Singapore 260
Ashburn 252
Houston 238
Ann Arbor 194
Cambridge 178
Wilmington 171
Chandler 161
Beijing 151
Seattle 145
Princeton 120
New York 109
Nanjing 97
Dearborn 82
Helsinki 69
Munich 64
Dublin 63
Istanbul 60
Brescia 44
Dong Ket 42
Milan 36
Moscow 33
Jinan 31
Nanchang 31
Boardman 30
Lancaster 30
Shenyang 29
San Francisco 28
Shanghai 28
Des Moines 25
Los Angeles 23
San Diego 23
Jiaxing 22
The Dalles 21
Changsha 19
Kunming 18
Tianjin 18
Hebei 17
Nuremberg 17
São Paulo 17
Jakarta 16
Toronto 16
Turku 16
Verona 16
Brooklyn 15
Chicago 15
Olomouc 15
Hangzhou 14
London 14
Florence 13
Zhengzhou 13
Haikou 12
Santa Clara 12
Brussels 10
Phoenix 10
Augusta 9
Leawood 9
San Mateo 9
Brno 7
Ningbo 7
Taizhou 7
Beersheba 6
Coimbatore 6
Dronten 6
Frankfurt am Main 6
Lanzhou 6
Monmouth Junction 6
Taiyuan 6
Amsterdam 5
Charlotte 5
Chennai 5
Hefei 5
Salò 5
Ardabil 4
Atlanta 4
Boston 4
Changchun 4
Council Bluffs 4
Dallas 4
Dhaka 4
Donegal 4
Fuzhou 4
Lappeenranta 4
Rio de Janeiro 4
Stockholm 4
Tokyo 4
Vienna 4
Athens 3
Baku 3
Barcelona 3
Bernareggio 3
Brasília 3
Colombo 3
Desio 3
Fiorenzuola D'arda 3
Hanoi 3
Totale 5.914
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 295
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 259
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 240
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 239
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 239
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 228
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 226
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 192
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 180
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 179
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 177
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 173
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 161
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 152
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 137
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 134
Sialic acid as a target for the development of novel antiangiogenic strategies 134
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 132
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 131
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 129
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 128
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 125
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 121
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 117
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 110
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 107
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 106
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 105
Role of heparan sulfate proteoglycans in HIV-1 Tat-induced transendothelial migration of lymphoid cells 103
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 101
Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona "variable" 99
Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity 98
Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF-receptors 94
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 93
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 92
Functional domains of basic fibroblast growth factor. Possible role of Asp-Gly-Arg sequences in the mitogenic activity of bFGF. 92
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain 88
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein 86
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 85
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 84
Recent Strategic Advances in CFTR Drug Discovery: An Overview 84
The basic domain in HIV-1 Tat as a target for polysulfated heparin-mimicking extracellular Tat antagonists 83
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 83
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 82
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 80
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 79
Inhibition of HIV-Tat angiogenic activity targeting HSPGs biosynthesis enzymes 78
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 77
Role of Syndecan-1 in HIV-1 Tat-induced chemotaxis of lymphoid cells 77
HIV-1 Tat and heparan sulfate proteoglycans: a novel mechanism of lymphocyte adhesion and migration across the endothelium 72
Thrombospondin/HIV-1 Tat protein interaction: modulation of the biologiocal activity of extracellular Tat 72
Thrombospondin-1: the paradigm of antiangiogenic agents endowed with multiple mechanisms of action 67
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 66
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorionallantoic membranes 63
Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: biological activity and intracellular fate of human recombinant Mr 24,000 bFGF 63
HIV-1 Tat and heparan sulfate proteoglycan interact to mediate lymphocyte adhesion and migration across the endothelium 62
Glycomics and angiogenesis: biological implications and therapeutical exploiting 58
heparan sulfate proteoglycans/HIV-1 Tat interaction: a mechanical and functional bridge between lymphoid and endothelial cells 58
HIV-1 Tat e iL monocita/macrofago: dall'interazione cellula/proteina all'insorgenza delle patologie associate all'AIDS 56
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 51
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 50
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein 49
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 49
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 47
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing 44
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms 40
Molecular dynamics simulations to investigate the dynamics and mechanism of action of carbohydrate-based polymers 38
UV-C EXPOSURE SUGGESTS A SARS-CoV-2 SPIKE PROTEIN ANTIVIRAL STRATEGY BASED ON REDUCING AGENTS 36
HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions 35
Exploring Alternative BAG3 Targeting Approaches for pediatric medulloblastoma: From small molecules lead optimization to Fragment-Based Drug Discovery 34
multidisciplinary approaches to rescue CFTR impairments by drug repositioning 34
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 33
Computational evaluation of the synergic effect of a small molecule on Lumacaftor F508del-CFTR rescue ability 32
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 32
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study 31
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 31
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 30
implementation of an incremental docking method to study long sugar chains interactions with proteins 29
DOES NICOTINAMIDE COMBINES WITH LUMACAFTOR TO IMPROVE F508del-CFTR RESCUE? 29
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 25
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein 25
THE ROLE OF GLYCOSAMINOGLYCANS IN SPIKE SARS-CoV-2 INFECTION: FROM A MODEL FOR HEPARAN SULFATES TO A STARTING STRUCTURE FOR ANTIVIRALS 23
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 22
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 19
Validation of plasmonic-based biosensors for rapid and in depth characterization of monoclonal antibodies directed against rabbit haemorrhagic and foot-and-mouth disease viruses in biological samples 18
HIV-1 Tat and heparan sulfate proteoglycans orchestrate the setup of in cis and in trans cells surface interactions functional to lymphocyte trans-endothelial migration 16
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 15
A drug repositioning pipeline to evaluate a synergic effect of small molecules on CFTR drugs 15
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound 13
HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension 12
The role of heparin in spike SARS-COV-2 infection: From a model for heparan sulfates to a starting structure for antivirals 11
Totale 8.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.924
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.091 37 101 44 130 73 124 42 140 131 79 115 75
2021/2022540 15 108 8 16 5 29 40 40 24 75 44 136
2022/2023438 64 19 26 19 29 125 7 46 63 3 12 25
2023/2024618 36 8 63 35 28 122 17 20 139 16 17 117
2024/20251.798 20 10 7 188 94 109 117 54 139 246 524 290
2025/2026143 143 0 0 0 0 0 0 0 0 0 0 0
Totale 8.099